ETFChannel.com
IONS Description — Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals is engaged in RNA-targeted therapeuty. Co.'s commercial products are SPINRAZA, TEGSEDI and WAYLIVRA. SPINRAZA injection for intrathecal use is a survival motor neuron-2 directed antisense medicine indicated for the treatment of spinal muscular atrophy in pediatric and adult patients. TEGSEDI injection is an RNA-targeted medicine indicated for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. WAYLIVRA is an antisense medicine indicated as an adjunct to diet in adult patients with genetically confirmed FCS and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate.

Company Name: 
Ionis Pharmaceuticals Inc
Website: 
www.ionispharma.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding IONS: 
50
Total Market Value Held by ETFs: 
$877,115,632.02
Total Market Capitalization: 
$5,686,000,000
% of Market Cap. Held by ETFs: 
15.43%
 ETF   IONS Weight   IONS Amount 
 VTI   0.01%   $170,140,520         
 VB   0.11%   $143,465,641         
 ARKG   4.71%   $116,085,546         
 VBK   0.26%   $82,843,932         
 XBI   0.95%   $82,088,214         
 VXF   0.09%   $79,106,271         
 FBT   3.29%   $51,981,452         
 IWP   0.14%   $18,320,760         
 VHT   0.09%   $18,246,822         
 IWF   0.03%   $17,613,275         
List of all 50 ETFs holding IONS »
Quotes delayed 20 minutes

Email EnvelopeFree IONS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (2.54 out of 4)
6th percentile
(ranked lower than approx. 94% of all stocks covered)

Analysts Forecast:
IONS Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding IONS | Ionis Pharmaceuticals Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.